PharmaceuticalIndustry

Supreme Court Takes Up the Fight Over Medicare Drug Price Negotiations

Supreme Court Weighs the Future of Medicare Drug Price Negotiations

Supreme Court Weighs In on Medicare's Push to Bargain for Prescription Drug Prices

Supreme Court’s Decision Keeps Medicare Drug Price Cuts in Place

The Pharmaceutical Frontier: Biosimilars on the Rise

Ivermectin's Unfulfilled Promise: A Potential Cancer Drug Quashed

The Unraveling of Kezar Life Sciences: How an FDA Delay Triggered a Biotech Startup's Collapse

Global Tensions Squeeze Indian Pharma: Rising Raw Material Costs a Growing Concern

Remembering Trump's Bold Move: The 100% Tariff Threat on Pharmaceuticals

Takeda Announces Significant Job Cuts, Centered on Cambridge R&D

A Child's Battle, An Insurance Denial: Mark Cuban Highlights Healthcare's Heartbreaking Flaws

A Game-Changer: Boost Pharma Welcomes Biotech Visionary Elaine Jones as New Board Chair

The Persistent Echo: Trump's Most Favored Nation Policy Still Shapes Drug Pricing Debates

The Future of Medicine: Unlocking Potential with Organoids and Spheroids

A Wake-Up Call for Big Pharma: FDA Cracks Down on Novo Nordisk

The Maverick Doctor Poised to Redefine Public Health in America

The Shadow of Geopolitics: Indian Pharma Exports to Middle East Face Uncertainty Amidst Rising Tensions

The Price of Life: Will South Africa Gain Access to Gilead's Breakthrough HIV Drug?

A Hard-Won Victory: Henrietta Lacks' Estate Secures Settlement with Novartis

A Critical Heads-Up for Ultragenyx (RARE) Investors: Understanding Your Rights in the Securities Class Action

The Cost of Cures: Unpacking the Price Tag of Novo Nordisk's Breakthrough Drugs in America

Taro Pharmaceuticals: A Bladder Cancer Setback Sparks a 15% After-Hours Slide – Is This a Buy-the-Dip Moment or a Sign of Deeper Trouble?

Unveiling the Truth: Are FDA Drug Studies Truly Robust?

Under the Microscope: Reassessing the Foundations of Our Medicines

Moderna's Ambitious mRNA Flu Vaccine Hits a Regulatory Snag

A Regulatory Stumble: FDA Puts Brakes on Moderna's Flu Vaccine Hopes

The Prescription Revolution: How Amazon is Reshaping Medicine Delivery

Weight-Loss Drug Wars Escalate: Novo Nordisk Sues Hims & Hers Over Compounded Semaglutide

The Weight-Loss Revolution: Telehealth Giant Hims & Hers Dives into the GLP-1 Market

Trump Launches TrumpRx: A Digital Crusade Against Sky-High Drug Prices

The Shifting Sands of US Drug Pricing: Why Big Pharma Investors are on Edge

The Market's Two Minds: Lilly's High-Stakes Game Meets Housing's Quiet Comeback

Pharmalot's Pulse Check: Navigating Pharma's Twists and Turns

Navigating Choppy Waters: Three Healthcare Stocks Facing Significant Headwinds This Quarter

Why Ozempic Isn't Denmark's Greenland Bargaining Chip with the US

The Shifting Sands of Pharma: Innovation, Access, and Lingering Questions in Early 2026

The Pharmaceutical Frontier: Navigating Breakthroughs, Billions, and Bitter Debates

The Unsung Heroes of Biotech: How Biological Buffers Are Fueling a $2.39 Billion Revolution

Big Pharma Breaks Silence: Confronting RFK Jr. on Vaccines